Related Experiment Video
Updated: Aug 30, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying
Anatoly Severin1, Keiko Tabei, Fred Tenover
1The Rockefeller University, New York, New York 10021, USA.
Abstract:
Recently, for the first time in the history of this bacterial species, methicillin-resistant Staphylococcus aureus (MRSA) carrying the enterococcal vanA gene complex and expressing high level resistance to vancomycin was identified in clinical specimens (CDC (2002) MMWR 51, 565-567). The purpose of our studies was to understand how vanA is expressed in the heterologous background of S. aureus and how it interacts with the mecA-based resistance mechanism, which is also present in these strains and is targeted on cell wall biosynthesis. The vanA-containing staphylococcal plasmid was transferred from the clinical vancomycin-resistant S. aureus (VRSA) strain HIP11714 (CDC (2002) MMWR 51, 565-567) to the methicillin-resistant S. aureus (MRSA) strain COL for which extensive genetic and biochemical information is available on staphylococcal cell wall biochemistry and drug resistance mechanisms. The transconjugant named COLVA showed high and homogeneous resistance to both oxacillin and vancomycin. COLVA grown in vancomycin-containing medium produced an abnormal peptidoglycan: all pentapeptides were replaced by tetrapeptides, and the peptidoglycan contained at least 22 novel muropeptide species that frequently showed a deficit or complete absence of pentaglycine branches. The UDP-MurNAc-pentapeptide, the major component of the cell wall precursor pool in vancomycin-sensitive cells was replaced by UDP-MurNAc-depsipeptide and UDP-MurNAc-tetrapeptide. Transposon inactivation of the beta-lactam resistance gene mecA caused complete loss of beta-lactam resistance but had no effect on the expression of vancomycin resistance. The two major antibiotic resistance mechanisms encoded by mecA and vanA residing in the same S. aureus appear to use different sets of enzymes for the assembly of cell walls.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) strains expressing vancomycin resistance (VRSA) were studied. VanA expression in S. aureus alters peptidoglycan synthesis, and mecA and vanA resistance mechanisms operate independently.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- First identification of methicillin-resistant Staphylococcus aureus (MRSA) with the enterococcal vanA gene complex and high-level vancomycin resistance (VRSA) in clinical settings.
- Existing knowledge of MRSA's mecA-based resistance targeting cell wall biosynthesis.
- Need to understand vanA expression in S. aureus and its interaction with mecA.
Purpose of the Study:
- To investigate the expression of the vanA gene in the heterologous S. aureus background.
- To determine how vanA interacts with the existing mecA-based resistance mechanism in S. aureus.
- To elucidate the impact of combined vanA and mecA resistance on cell wall biosynthesis.
Main Methods:
- Transfer of the vanA-containing staphylococcal plasmid from a clinical VRSA strain (HIP11714) to an MRSA strain (COL).
- Characterization of the resulting transconjugant (COLVA) for antibiotic resistance profiles.
- Analysis of peptidoglycan structure and cell wall precursor pools in COLVA.
- Experimental inactivation of the mecA gene in COLVA to assess its effect on vancomycin resistance.
Main Results:
- The transconjugant COLVA exhibited high and homogeneous resistance to both oxacillin and vancomycin.
- Vancomycin exposure in COLVA led to abnormal peptidoglycan, with pentapeptides replaced by tetrapeptides and altered branching.
- Key cell wall precursors shifted from UDP-MurNAc-pentapeptide to UDP-MurNAc-depsipeptide and UDP-MurNAc-tetrapeptide.
- Transposon inactivation of mecA abolished beta-lactam resistance but did not affect vancomycin resistance.
Conclusions:
- The vanA gene complex can be effectively expressed in S. aureus, conferring high-level vancomycin resistance.
- Combined expression of vanA and mecA in S. aureus results in distinct alterations to cell wall peptidoglycan synthesis.
- The mecA and vanA antibiotic resistance mechanisms in S. aureus appear to utilize separate enzymatic pathways for cell wall assembly.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Staphylococcal Skin Infections
Antibiotic Selection